A draft guidance titled, "Intent to Exempt Certain Class II and Class I Reserved Medical Devices from Premarket Notification Requirements" has recently been posted. This draft guidance describes the FDA’s intent to exempt certain Class II medical devices and certain Class I medical devices that are subject to the reserved criteria of section 510(l) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 360(l), from premarket submission requirements. The FDA believes devices identified in section 4 of this guidance document are sufficiently well understood and do not present risks that require premarket notification (510(k)) review to assure their safety and effectiveness. For more information, please see: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM407292.pdf
Subscriber Services:
Manage Preferences | Unsubscribe | Help with this service
| Stay Connected: | |||||||||||||
 |  |  |  |  |  | ||||||||
Excellent customer service is important to us. Please take a moment to provide feedback regarding the customer service you have received by taking our Customer Service Survey.
| This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
